↑ Grab this Headline Animator

View A Detailed Listing Of All Ranbaxy Laboratories Deals And Alliances...

Research and Markets (http://www.researchandmarkets.com/reports/c38649) has announced the addition of 's8220;Ranbaxy Laboratories Limited Deals Briefing's8221; to their offering.



Partneringdesk Ranbaxy Laboratories Ltd Deals Briefing provides an in-depth view of the 37 deals made by Ranbaxy Laboratories Ltd and its subsidiaries with 41 partnering companies between 2001 and 2006, in a clear and accessible PDF format.



Chapter 1 gives a complete company profile containing an overview of the company, including contact details, and expertise in terms of industry sector, therapy focus and management. In Chapter 2, financial data and deals are examined, giving a detailed summary of the company's8217;s financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector.

Chapter 3 provides a summary of deals; a comprehensive overview listing deals by partner company, subsidiary, therapy focus, development stage, deal type and industry sector with a full index of all the deals announced. Chapter 4 contains a detailed listing of all the company's8217;s deals and alliances announced between January 2001 and March 2006.

Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront and milestone payments, where disclosed.



Reasons to purchase (USPs and key questions answered):

Partneringdesk Ranbaxy Laboratories Ltd Deals Briefing provides a comprehensive summary of the deals and alliances announced by the company and its subsidiaries between January 2001 and March 2006. This report helps in:

-identifying active partners

-tracking competitor activity

-benchmarking deals

-comparing the finances of different deal types.



Partneringdesk Ranbaxy Laboratories Ltd Deals Briefing brings all relevant partnering deals into one place, providing a reference to deal making by Ranbaxy Laboratories Ltd.



Forecasts, projections, market estimates:

This report provides: a financial summary table detailing the yearly total revenues, pharma revenues, R&D spend and profit of the company; and a series of tables detailing the number of deals made by deal type, by therapy focus, by development stage and by industry sector.



Who should buy the report:

This report is essential reading for board and executive management, and individuals in:

-business development

-licensing/partnering

-deal making   


-business strategy

-marketing and promotion

-distribution and manufacturing (including contract services).



Methodology:

This report is derived from data obtained from Pharmalicensing's8217;s Partneringdesk deals and alliances database. The database is updated daily using industry sources.

The report includes deals made by Ranbaxy Laboratories Ltd between January 2001 and March 2006 and the following subsidiaries (where available):

- Laboratorios Ranbaxy SL

- Ohm Laboratories

- Ranbaxy Pharmaceuticals



For more information visit http://www.researchandmarkets.com/reports/c38649



Laura Wood

Senior Manager

Research and Markets

Fax: +353 1 4100 980

↑ Grab this Headline Animator

---

This article has been robotically scanned and tagged by Prnewsnow with the following search tags. No human manipulation of these tags take place.
| Maestro | Maestro Analytics | maestro analytics business |

---

4869 readers online...

, Local News